Gurses KM - Search Results

1

Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women.

Greco D, Kocyigit D, Adorni MP, Marchi C, Ronda N, Bernini F, Gurses KM, Canpinar H, Guc D, Oguz SH, Gurlek A, Strazzella A, Simonelli S, Tokgozoglu L, Zimetti F. Greco D, et al. Among authors: gurses km. Nutr Metab Cardiovasc Dis. 2018 Aug;28(8):822-829. doi: 10.1016/j.numecd.2018.04.010. Epub 2018 May 12. Nutr Metab Cardiovasc Dis. 2018. PMID: 29954641

2

Markers of subclinical atherosclerosis in premenopausal women with vitamin D deficiency and effect of vitamin D replacement.

Gurses KM, Tokgozoglu L, Yalcin MU, Kocyigit D, Dural M, Canpinar H, Yorgun H, Sahiner ML, Kaya EB, Akin S, Gurlek A, Guc D, Aytemir K. Gurses KM, et al. Atherosclerosis. 2014 Dec;237(2):784-9. doi: 10.1016/j.atherosclerosis.2014.10.096. Epub 2014 Oct 29. Atherosclerosis. 2014. PMID: 25463121

3

Epicardial Fat Thickness is Increased in Vitamin D Deficient Premenopausal Women and does not Decrease after Short-term Replacement.

Gurses KM, Tokgozoglu L, Yalcin MU, Kocyigit D, Evranos B, Yorgun H, Sahiner L, Kaya EB, Kabakci G, Gurlek A, Ozer N, Aytemir K. Gurses KM, et al. J Atheroscler Thromb. 2015;22(6):582-9. doi: 10.5551/jat.28381. Epub 2015 Jan 28. J Atheroscler Thromb. 2015. PMID: 25739691 Free article.

4

Role of Micronutrients on Subclinical Atherosclerosis Micronutrients in Subclinical Atherosclerosis.

Kocyigit D, Gurses KM, Yalcin MU, Tokgozoglu L. Kocyigit D, et al. Among authors: gurses km. Curr Pharm Des. 2016;22(2):221-9. doi: 10.2174/1381612822666151112150020. Curr Pharm Des. 2016. PMID: 26561073 Review.

5

Anti-inflammatory therapy in atherosclerosis.

Kocyigit D, Gurses KM, Tokgozoglu L. Kocyigit D, et al. Among authors: gurses km. Front Biosci (Landmark Ed). 2020 Jan 1;25(2):242-269. doi: 10.2741/4805. Front Biosci (Landmark Ed). 2020. PMID: 31585888 Free article. Review.

6

Elevated Serum Beta-Trace Protein Levels are Associated With the Presence of Atrial Fibrillation in Hypertension Patients.

Yalcin MU, Gurses KM, Kocyigit D, Kesikli SA, Tokgozoglu L, Guc D, Aytemir K, Ozer N. Yalcin MU, et al. Among authors: gurses km. J Clin Hypertens (Greenwich). 2016 May;18(5):439-43. doi: 10.1111/jch.12703. Epub 2015 Oct 5. J Clin Hypertens (Greenwich). 2016. PMID: 26435487 Free PMC article.

7

Reply: To PMID 25604929.

Kocyigit D, Gurses KM. Kocyigit D, et al. Among authors: gurses km. Am J Cardiol. 2015 Jul 1;116(1):164. doi: 10.1016/j.amjcard.2015.04.005. Epub 2015 Apr 13. Am J Cardiol. 2015. PMID: 25956625 No abstract available.

8

Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade.

Kocyigit D, Gurses KM, Yalcin MU, Tokgozoglu L. Kocyigit D, et al. Among authors: gurses km. Endocr Metab Immune Disord Drug Targets. 2017;17(1):19-31. doi: 10.2174/1871530317666170424101846. Endocr Metab Immune Disord Drug Targets. 2017. PMID: 28440199 Review.

9

Management of Blood Pressure and Heart Rate in Acute Decompensated Heart Failure with Volume Overload.

Kocyigit D, Gurses KM, Yalcin MU, Tokgozoglu L. Kocyigit D, et al. Among authors: gurses km. Curr Pharm Des. 2017;23(31):4609-4619. doi: 10.2174/1381612823666170526102159. Curr Pharm Des. 2017. PMID: 28552064 Review.

10

Effects of persistent atrial fibrillation on serum galectin-3 levels.

Gurses KM, Yalcin MU, Kocyigit D, Canpinar H, Evranos B, Yorgun H, Sahiner ML, Kaya EB, Ozer N, Tokgozoglu L, Oto MA, Guc D, Aytemir K. Gurses KM, et al. Am J Cardiol. 2015 Mar 1;115(5):647-51. doi: 10.1016/j.amjcard.2014.12.021. Epub 2014 Dec 18. Am J Cardiol. 2015. PMID: 25604929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters